List of Tables
Table 1. Global Hemostatic Agents Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Hemostatic Agents Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Hemostatic Agents Market Competitive Situation by Manufacturers in 2025
Table 4. Global Hemostatic Agents Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Hemostatic Agents Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Hemostatic Agents Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Hemostatic Agents Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Hemostatic Agents Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Hemostatic Agents, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Hemostatic Agents, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Hemostatic Agents, Product Types and Applications
Table 12. Global Key Manufacturers of Hemostatic Agents, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hemostatic Agents Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hemostatic Agents Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hemostatic Agents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Hemostatic Agents Sales by Region (K Units), 2021–2026
Table 18. Global Hemostatic Agents Sales Market Share by Region (2021–2026)
Table 19. Global Hemostatic Agents Sales by Region (K Units), 2027–2032
Table 20. Global Hemostatic Agents Sales Market Share by Region (2027–2032)
Table 21. Global Hemostatic Agents Revenue by Region (US$ Million), 2021–2026
Table 22. Global Hemostatic Agents Revenue Market Share by Region (2021–2026)
Table 23. Global Hemostatic Agents Revenue by Region (US$ Million), 2027–2032
Table 24. Global Hemostatic Agents Revenue Market Share by Region (2027–2032)
Table 25. North America Hemostatic Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Hemostatic Agents Sales by Country (K Units), 2021–2026
Table 27. North America Hemostatic Agents Sales by Country (K Units), 2027–2032
Table 28. North America Hemostatic Agents Revenue by Country (US$ Million), 2021–2026
Table 29. North America Hemostatic Agents Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Hemostatic Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Hemostatic Agents Sales by Country (K Units), 2021–2026
Table 32. Europe Hemostatic Agents Sales by Country (K Units), 2027–2032
Table 33. Europe Hemostatic Agents Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Hemostatic Agents Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Hemostatic Agents Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Hemostatic Agents Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Hemostatic Agents Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Hemostatic Agents Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Hemostatic Agents Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Hemostatic Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Hemostatic Agents Sales by Country (K Units), 2021–2026
Table 42. Latin America Hemostatic Agents Sales by Country (K Units), 2027–2032
Table 43. Latin America Hemostatic Agents Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Hemostatic Agents Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Hemostatic Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Hemostatic Agents Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Hemostatic Agents Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Hemostatic Agents Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Hemostatic Agents Revenue by Country (US$ Million), 2027–2032
Table 50. Global Hemostatic Agents Sales (K Units) by Type (2021–2026)
Table 51. Global Hemostatic Agents Sales (K Units) by Type (2027–2032)
Table 52. Global Hemostatic Agents Sales Market Share by Type (2021–2026)
Table 53. Global Hemostatic Agents Sales Market Share by Type (2027–2032)
Table 54. Global Hemostatic Agents Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Hemostatic Agents Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Hemostatic Agents Revenue Market Share by Type (2021–2026)
Table 57. Global Hemostatic Agents Revenue Market Share by Type (2027–2032)
Table 58. Global Hemostatic Agents Price (USD/Unit) by Type (2021–2026)
Table 59. Global Hemostatic Agents Price (USD/Unit) by Type (2027–2032)
Table 60. Global Hemostatic Agents Sales (K Units) by Application (2021–2026)
Table 61. Global Hemostatic Agents Sales (K Units) by Application (2027–2032)
Table 62. Global Hemostatic Agents Sales Market Share by Application (2021–2026)
Table 63. Global Hemostatic Agents Sales Market Share by Application (2027–2032)
Table 64. Global Hemostatic Agents Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Hemostatic Agents Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Hemostatic Agents Revenue Market Share by Application (2021–2026)
Table 67. Global Hemostatic Agents Revenue Market Share by Application (2027–2032)
Table 68. Global Hemostatic Agents Price (USD/Unit) by Application (2021–2026)
Table 69. Global Hemostatic Agents Price (USD/Unit) by Application (2027–2032)
Table 70. Ethicon Company Information
Table 71. Ethicon Description and Business Overview
Table 72. Ethicon Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. Ethicon Hemostatic Agents Product
Table 74. Ethicon Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Hemostatic Agents Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Baxter International Company Information
Table 81. Baxter International Description and Business Overview
Table 82. Baxter International Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. Baxter International Hemostatic Agents Product
Table 84. Baxter International Recent Developments/Updates
Table 85. C. R. Bard Company Information
Table 86. C. R. Bard Description and Business Overview
Table 87. C. R. Bard Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. C. R. Bard Hemostatic Agents Product
Table 89. C. R. Bard Recent Developments/Updates
Table 90. The Medicines Company Company Information
Table 91. The Medicines Company Description and Business Overview
Table 92. The Medicines Company Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. The Medicines Company Hemostatic Agents Product
Table 94. The Medicines Company Recent Developments/Updates
Table 95. Anika Therapeutics Company Information
Table 96. Anika Therapeutics Description and Business Overview
Table 97. Anika Therapeutics Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. Anika Therapeutics Hemostatic Agents Product
Table 99. Anika Therapeutics Recent Developments/Updates
Table 100. Advanced Medical Solutions Company Information
Table 101. Advanced Medical Solutions Description and Business Overview
Table 102. Advanced Medical Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. Advanced Medical Solutions Hemostatic Agents Product
Table 104. Advanced Medical Solutions Recent Developments/Updates
Table 105. Integra LifeSciences Company Information
Table 106. Integra LifeSciences Description and Business Overview
Table 107. Integra LifeSciences Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. Integra LifeSciences Hemostatic Agents Product
Table 109. Integra LifeSciences Recent Developments/Updates
Table 110. B Braun Melsungen Company Information
Table 111. B Braun Melsungen Description and Business Overview
Table 112. B Braun Melsungen Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. B Braun Melsungen Hemostatic Agents Product
Table 114. B Braun Melsungen Recent Developments/Updates
Table 115. Gelita Medical Company Information
Table 116. Gelita Medical Description and Business Overview
Table 117. Gelita Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 118. Gelita Medical Hemostatic Agents Product
Table 119. Gelita Medical Recent Developments/Updates
Table 120. Equimedical Company Information
Table 121. Equimedical Description and Business Overview
Table 122. Equimedical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 123. Equimedical Hemostatic Agents Product
Table 124. Equimedical Recent Developments/Updates
Table 125. Vascular Solutions Company Information
Table 126. Vascular Solutions Description and Business Overview
Table 127. Vascular Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 128. Vascular Solutions Hemostatic Agents Product
Table 129. Vascular Solutions Recent Developments/Updates
Table 130. Marine Polymer Technologies Company Information
Table 131. Marine Polymer Technologies Description and Business Overview
Table 132. Marine Polymer Technologies Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 133. Marine Polymer Technologies Hemostatic Agents Product
Table 134. Marine Polymer Technologies Recent Developments/Updates
Table 135. Z-Medica Company Information
Table 136. Z-Medica Description and Business Overview
Table 137. Z-Medica Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 138. Z-Medica Hemostatic Agents Product
Table 139. Z-Medica Recent Developments/Updates
Table 140. CryoLife Company Information
Table 141. CryoLife Description and Business Overview
Table 142. CryoLife Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 143. CryoLife Hemostatic Agents Product
Table 144. CryoLife Recent Developments/Updates
Table 145. BioCer Entwicklungs Company Information
Table 146. BioCer Entwicklungs Description and Business Overview
Table 147. BioCer Entwicklungs Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 148. BioCer Entwicklungs Hemostatic Agents Product
Table 149. BioCer Entwicklungs Recent Developments/Updates
Table 150. Biom’Up SAS Company Information
Table 151. Biom’Up SAS Description and Business Overview
Table 152. Biom’Up SAS Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 153. Biom’Up SAS Hemostatic Agents Product
Table 154. Biom’Up SAS Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Hemostatic Agents Distributors List
Table 158. Hemostatic Agents Customers List
Table 159. Hemostatic Agents Market Trends
Table 160. Hemostatic Agents Market Drivers
Table 161. Hemostatic Agents Market Challenges
Table 162. Hemostatic Agents Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hemostatic Agents
Figure 2. Global Hemostatic Agents Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Hemostatic Agents Market Share by Type: 2025 & 2032
Figure 4. Gelation Sponge Product Picture
Figure 5. Oxidized Regenerated Cellulose Based Hemostats Product Picture
Figure 6. Others Product Picture
Figure 7. Global Hemostatic Agents Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Hemostatic Agents Market Share by Application: 2025 & 2032
Figure 9. Hospitals
Figure 10. Surgical Centers
Figure 11. Nursing Homes
Figure 12. Global Hemostatic Agents Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Hemostatic Agents Market Size (US$ Million), 2021–2032
Figure 14. Global Hemostatic Agents Sales (K Units), 2021–2032
Figure 15. Global Hemostatic Agents Average Price (USD/Unit), 2021–2032
Figure 16. Hemostatic Agents Report Years Considered
Figure 17. Hemostatic Agents Sales Share by Manufacturers in 2025
Figure 18. Global Hemostatic Agents Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Hemostatic Agents Players: Market Share by Revenue in Hemostatic Agents in 2025
Figure 20. Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Hemostatic Agents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Hemostatic Agents Sales Market Share by Country (2021–2032)
Figure 23. North America Hemostatic Agents Revenue Market Share by Country (2021–2032)
Figure 24. U.S. Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Hemostatic Agents Sales Market Share by Country (2021–2032)
Figure 27. Europe Hemostatic Agents Revenue Market Share by Country (2021–2032)
Figure 28. Germany Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Hemostatic Agents Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Hemostatic Agents Revenue Market Share by Region (2021–2032)
Figure 35. China Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Philippines Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Hemostatic Agents Sales Market Share by Country (2021–2032)
Figure 46. Latin America Hemostatic Agents Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Hemostatic Agents Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Hemostatic Agents Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. U.A.E Hemostatic Agents Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Hemostatic Agents by Type (2021–2032)
Figure 56. Global Revenue Market Share of Hemostatic Agents by Type (2021–2032)
Figure 57. Global Hemostatic Agents Price (USD/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Hemostatic Agents by Application (2021–2032)
Figure 59. Global Revenue Market Share of Hemostatic Agents by Application (2021–2032)
Figure 60. Global Hemostatic Agents Price (USD/Unit) by Application (2021–2032)
Figure 61. Hemostatic Agents Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
